Event

Peter M. Calverley

DSc, F MedSci
Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool;Institute of Ageing and Chronic Disease, University of Liverpool;University of Liverpool;University of Liverpo

Julie Yates

BS
GlaxoSmithKline;GSK

Nicholas J. Cowans

BSc, MSc
Veramed Ltd

Courtney Crim

MD
GlaxoSmithKline

David E. Newby

BA BSc PhD BM DM DSc FRSE FMedSci FESC FACC
University of Edinburgh

Julie A. Anderson

BSc, MA, MBA
GlaxoSmithKline

Robert A. Wise

MD
Johns Hopkins Bayview;Johns Hopkins Medicine;Johns Hopkins Univ;Johns Hopkins University;Johns Hopkins University School of Medicine

Emily P. Brigham

MD, MHS
Johns Hopkins;Johns Hopkins Univ;Johns Hopkins University School of Medicine

Fernando J. Martinez

MD, MS
Cornell University;New York-Presbyterian Hospital/Weill Cornell Medical Center;Weill Cornell Medical College;Weill Cornell Medical College, Cornell University;Weill Cornell Medicine

James E. Diserens

BSc
Veramed Ltd

Bartolome R. Celli

MD
Brigham and Women's Hospital;Brigham and Women's Hospital, Harvard Medical School;Harvard Medical School;Pulmonary Division

Robert D. Brook

MD
University of Michigan Division of Cardiovascular Medicine

Jorgen Vestbo

MD, PhD
Manchester Academic Health Sciences Centre, The University of Manchester and Manchester University N;Manchester Academic Health Sciences Centre, The University of Manchester and University Hospital So

Challenging the Obesity Paradox: Effect of Extreme Obesity on COPD Mortality in Patients with Heightened Cardiovascular Risk